These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 26355018)

  • 1. Gadofosveset trisodium-enhanced MR angiography for detection of lower gastrointestinal bleeding.
    Hanna RF; Browne WF; Khanna LG; Prince MR; Hecht EM
    Clin Imaging; 2015; 39(6):1052-5. PubMed ID: 26355018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of gadofosveset-enhanced three-dimensional magnetic resonance angiography with digital subtraction angiography for lower-extremity peripheral arterial occlusive disease.
    Grijalba FU; Esandi MC
    Acta Radiol; 2010 Apr; 51(3):284-9. PubMed ID: 20105092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gadobenate dimeglumine and gadofosveset trisodium for MR angiography of the renal arteries: Multicenter intraindividual crossover comparison.
    Schneider G; Pasowicz M; Vymazal J; Seidl Z; Aschauer M; Konopka M; Bilecen D; Iezzi R; Ballarati C
    AJR Am J Roentgenol; 2010 Aug; 195(2):476-85. PubMed ID: 20651208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multi-center, comparative, phase 3 study to determine the efficacy of gadofosveset-enhanced magnetic resonance angiography for evaluation of renal artery disease.
    McGregor R; Vymazal J; Martinez-Lopez M; Neuwirth J; Salgado P; Beregi JP; Peduto A; de la Pena-Almaguer E; Slater GJ; Shamsi K; Parsons EC
    Eur J Radiol; 2008 Feb; 65(2):316-25. PubMed ID: 17499952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active gastrointestinal hemorrhage identification by blood pool contrast-enhanced magnetic resonance angiography.
    Williams J; Vasanawala SS
    Pediatr Radiol; 2011 Sep; 41(9):1198-200. PubMed ID: 21594539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aortoiliac occlusive disease in patients with known or suspected peripheral vascular disease: safety and efficacy of gadofosveset-enhanced MR angiography--multicenter comparative phase III study.
    Rapp JH; Wolff SD; Quinn SF; Soto JA; Meranze SG; Muluk S; Blebea J; Johnson SP; Rofsky NM; Duerinckx A; Foster GS; Kent KC; Moneta G; Middlebrook MR; Narra VR; Toombs BD; Pollak J; Yucel EK; Shamsi K; Weisskoff RM
    Radiology; 2005 Jul; 236(1):71-8. PubMed ID: 15987963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-pass whole-body magnetic resonance angiography (MRA) using the blood-pool contrast medium gadofosveset trisodium: comparison to gadopentetate dimeglumine.
    Klessen C; Hein PA; Huppertz A; Voth M; Wagner M; Elgeti T; Kroll H; Hamm B; Taupitz M; Asbach P
    Invest Radiol; 2007 Sep; 42(9):659-64. PubMed ID: 17700282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gadofosveset--a blood pool contrast agent used with MRI to detect obscure gastrointestinal bleeding: a case report.
    Jacobi B; Schubert T; Partovi S; Loebe M; Lumsden AB; Zipp L; Pansini M; Bilecen D
    Am J Gastroenterol; 2012 Jul; 107(7):1107-9. PubMed ID: 22764032
    [No Abstract]   [Full Text] [Related]  

  • 9. Highly accelerated first-pass contrast-enhanced magnetic resonance angiography of the peripheral vasculature: comparison of gadofosveset trisodium with gadopentetate dimeglumine contrast agents.
    Maki JH; Wang M; Wilson GJ; Shutske MG; Leiner T
    J Magn Reson Imaging; 2009 Nov; 30(5):1085-92. PubMed ID: 19856442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of gadofosveset trisodium and gadobenate dimeglumine during time-resolved thoracic MR angiography at 3T.
    Frydrychowicz A; Russe MF; Bock J; Stalder AF; Bley TA; Harloff A; Markl M
    Acad Radiol; 2010 Nov; 17(11):1394-400. PubMed ID: 20650665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of contrast-enhanced MR angiography to intraarterial digital subtraction angiography for evaluation of peripheral arterial occlusive disease: results of a phase III multicenter trial.
    Bui BT; Miller S; Mildenberger P; Sam A; Sheng R;
    J Magn Reson Imaging; 2010 Jun; 31(6):1402-10. PubMed ID: 20512893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-body magnetic resonance angiography with additional steady-state acquisition of the infragenicular arteries in patients with peripheral arterial disease.
    Nielsen YW; Eiberg JP; Løgager VB; Just S; Schroeder TV; Thomsen HS
    Cardiovasc Intervent Radiol; 2010 Jun; 33(3):484-91. PubMed ID: 19957180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pedal angiography in peripheral arterial occlusive disease: first-pass i.v. contrast-enhanced MR angiography with blood pool contrast medium versus intraarterial digital subtraction angiography.
    Kos S; Reisinger C; Aschwanden M; Bongartz GM; Jacob AL; Bilecen D
    AJR Am J Roentgenol; 2009 Mar; 192(3):775-84. PubMed ID: 19234277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-resolved contrast-enhanced MRA (TWIST) with gadofosveset trisodium in the classification of soft-tissue vascular anomalies in the head and neck in children following updated 2014 ISSVA classification: first report on systematic evaluation of MRI and TWIST in a cohort of 47 children.
    Higgins LJ; Koshy J; Mitchell SE; Weiss CR; Carson KA; Huisman TA; Tekes A
    Clin Radiol; 2016 Jan; 71(1):32-9. PubMed ID: 26474946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gadofosveset-enhanced MR angiography of carotid arteries: does steady-state imaging improve accuracy of first-pass imaging? Comparison with selective digital subtraction angiography.
    Anzidei M; Napoli A; Marincola BC; Nofroni I; Geiger D; Zaccagna F; Catalano C; Passariello R
    Radiology; 2009 May; 251(2):457-66. PubMed ID: 19401574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-pass and steady-state magnetic resonance angiography of the thoracic vasculature using gadofosveset trisodium.
    Naehle CP; Müller A; Willinek WA; Meyer C; Hestermann T; Gieseke J; Schild H; Thomas D
    J Magn Reson Imaging; 2009 Oct; 30(4):809-16. PubMed ID: 19787726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of gadofosveset-enhanced MR angiography for evaluation of pedal arterial disease: multicenter comparative phase 3 study.
    Bosch E; Kreitner KF; Peirano MF; Thurnher S; Shamsi K; Parsons EC
    AJR Am J Roentgenol; 2008 Jan; 190(1):179-86. PubMed ID: 18094309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gadofosveset trisodium-enhanced magnetic resonance angiography of the left atrium--a feasibility study.
    Wagner M; Rief M; Asbach P; Vogtmann T; Huppertz A; Beling M; Butler C; Laule M; Warmuth C; Taupitz M; Hamm B; Lembcke A
    Eur J Radiol; 2010 Aug; 75(2):166-72. PubMed ID: 19464133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast-enhanced MRA of the renal and aorto-iliac-femoral arteries: comparison of gadobenate dimeglumine and gadofosveset trisodium.
    Iezzi R; Soulez G; Thurnher S; Schneider G; Kirchin MA; Shen N; Pirovano G; Spinazzi A
    Eur J Radiol; 2011 Feb; 77(2):358-68. PubMed ID: 19679417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Part 2 - Coronary angiography with gadofosveset trisodium: a prospective intra-subject comparison for dose optimization for 100 % efficiency imaging.
    Ahlman MA; Raman FS; Pang J; Zemrak F; Sandfort V; Penzak SR; Fan Z; Liu S; Li D; Bluemke DA
    BMC Cardiovasc Disord; 2016 Mar; 16():58. PubMed ID: 27004532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.